Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
about
Group B Streptococcus vaccine: state of the artStimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy.A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts.Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons.Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant womenA protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C proteinTransmission probabilities and durations of immunity for three pathogenic group B Streptococcus serotypesCurrent status of meningococcal group B vaccine candidates: capsular or noncapsular?Group B Streptococcus: global incidence and vaccine development.Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.Characterization of two distinct opsonic and protective epitopes within the alpha C protein of the group B Streptococcus.
P2860
Q26796438-E7E72729-D01E-4997-8936-063E7B650B18Q33614322-E1257109-13DC-47C8-B5CD-312C28EC31EFQ33753897-AAC4E34B-844D-45AF-8C1D-074A4FD7CDD9Q33963795-5D8295CA-F662-4A43-8BBD-AA8F5902733DQ34130285-DDB5D771-6E5F-4F9B-A02B-0DC8DEB7AFB9Q34235531-A4659E31-BB62-4766-A3FA-B313C9A43AA4Q34532914-D012585E-070F-42E3-A9E9-AA751E1996D6Q35470773-ED270784-54FD-4347-BD86-CCEE3A945E35Q35489205-FB5EF83A-3492-4234-9E5C-3E935B7C1B2FQ35525444-4668DD9D-BE03-4A8B-8F76-B031F0FABEE4Q36082709-691DCF6B-187E-41D4-A011-EBF263B8BA05Q36642138-8E168A3A-CD06-45D3-8F63-EE89BAB48310Q36646803-61621680-54B5-49C6-A9AC-72DCE877F691Q37074015-957D651E-28D2-47B9-837A-1EC22A8CA442Q37361495-FFBDC57B-8E00-4D41-8F7B-F1380D1D440FQ39829516-60CBD602-847E-45F2-94C7-7428470C72C9
P2860
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
@en
type
label
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
@en
prefLabel
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
@en
P2093
P2860
P1476
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
@en
P2093
D L Kasper
H J Jennings
L C Paoletti
M R Wessels
P2860
P304
P407
P577
1992-10-01T00:00:00Z